EnFuego Therapeutics Inc.
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$2.05M
Company Overview
EnFuego Therapeutics Inc. is a drug discovery company developing RNA interference-based and antisense oligo therapeutics to treat lung, pancreatic, and colon cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnFuego Therapeutics Inc. Comparables
Compare EnFuego Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Silexion Therapeutics Corp. | 78% | |
| VesiCURE Therapeutics | 77% | |
| Kestrel Therapeutics | 73% |
EnFuego Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Seed | Jun 15, 2021 | ||||
| Accelerator | May 21, 2020 | ||||
| Grant | Mar 16, 2020 |
EnFuego Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| KickStart Venture Services | Accelerator |
| NIH RADx | Grant |
| North Carolina Biotechnology Center | Grant |
| Fox Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
$919K grant received from National Cancer Institute and NIH RADx.
- Jun 15, 2021
$500K raised with Fox Ventures participating.
EnFuego Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EnFuego Therapeutics Inc.'s valuation, stock price, and market status.
Is EnFuego Therapeutics Inc. a public or private company?
EnFuego Therapeutics Inc. is a private company.
What is the current stock price of EnFuego Therapeutics Inc.?
EnFuego Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is EnFuego Therapeutics Inc. worth (valuation)?
Valuation information for EnFuego Therapeutics Inc. is not publicly available.
Can I buy EnFuego Therapeutics Inc. stock?
EnFuego Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EnFuego Therapeutics Inc.'s last funding round?
EnFuego Therapeutics Inc.'s most recent funding round was Grant on July 1, 2024.
Who are the main investors in EnFuego Therapeutics Inc.?
Key investors in EnFuego Therapeutics Inc. include National Cancer Institute, KickStart Venture Services, NIH RADx, North Carolina Biotechnology Center, Fox Ventures.
Will EnFuego Therapeutics Inc. IPO soon?
No public IPO plans have been announced for EnFuego Therapeutics Inc..
How can I track EnFuego Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EnFuego Therapeutics Inc.'s secondary market activity and sign up for updates.